-
1
-
-
33747143361
-
From vanilla to 28 flavors: Multiple varieties of T regulatory cells
-
Shevach EM. From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 2006 25 : 195 201.
-
(2006)
Immunity
, vol.25
, pp. 195-201
-
-
Shevach, E.M.1
-
4
-
-
0347785480
-
Control of regulatory T cell development by the transcription factor Foxp3
-
Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003 299 : 1057 1061.
-
(2003)
Science
, vol.299
, pp. 1057-1061
-
-
Hori, S.1
Nomura, T.2
Sakaguchi, S.3
-
5
-
-
38349095578
-
Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer
-
Tone Y, Furuuchi K, Kojima Y, Tykocinski ML, Greene MI, Tone M. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol 2008 9 : 194 202.
-
(2008)
Nat Immunol
, vol.9
, pp. 194-202
-
-
Tone, Y.1
Furuuchi, K.2
Kojima, Y.3
Tykocinski, M.L.4
Greene, M.I.5
Tone, M.6
-
6
-
-
34447265236
-
CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: A role for DNA methylation
-
Kim HP, Leonard WJ. CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J Exp Med 2007 204 : 1543 1551.
-
(2007)
J Exp Med
, vol.204
, pp. 1543-1551
-
-
Kim, H.P.1
Leonard, W.J.2
-
7
-
-
0037038402
-
The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease
-
Youssef S, Stuve O, Patarroyo JC et al. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 2002 420 : 78 84.
-
(2002)
Nature
, vol.420
, pp. 78-84
-
-
Youssef, S.1
Stuve, O.2
Patarroyo, J.C.3
-
8
-
-
39649089195
-
Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity
-
Zeiser R, Youssef S, Baker J, Kambham N, Steinman L, Negrin RS. Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity. Blood 2007 110 : 4588 4598.
-
(2007)
Blood
, vol.110
, pp. 4588-4598
-
-
Zeiser, R.1
Youssef, S.2
Baker, J.3
Kambham, N.4
Steinman, L.5
Negrin, R.S.6
-
9
-
-
20044383914
-
A prospective trial to evaluate the safety and efficacy of pravastatin for the treatment of refractory chronic graft-versus-host disease
-
Hori A, Kanda Y, Goyama S et al. A prospective trial to evaluate the safety and efficacy of pravastatin for the treatment of refractory chronic graft-versus-host disease. Transplantation 2005 79 : 372 374.
-
(2005)
Transplantation
, vol.79
, pp. 372-374
-
-
Hori, A.1
Kanda, Y.2
Goyama, S.3
-
10
-
-
33344475402
-
Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin
-
Dunn SE, Youssef S, Goldstein MJ, Prod'homme T, Weber MS, Zamvil SS, Steinman L. Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin. J Exp Med 2006 203 : 401 412.
-
(2006)
J Exp Med
, vol.203
, pp. 401-412
-
-
Dunn, S.E.1
Youssef, S.2
Goldstein, M.J.3
Prod'Homme, T.4
Weber, M.S.5
Zamvil, S.S.6
Steinman, L.7
-
11
-
-
0034948339
-
Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site
-
Weitz-Schmidt G, Welzenbach K, Brinkmann V et al. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med 2001 7 : 687 692.
-
(2001)
Nat Med
, vol.7
, pp. 687-692
-
-
Weitz-Schmidt, G.1
Welzenbach, K.2
Brinkmann, V.3
-
12
-
-
32244445416
-
Natural regulatory T cells control the development of atherosclerosis in mice
-
DOI 10.1038/nm1343, PII NM1343
-
Ait-Oufella H, Salomon BL, Potteaux S et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 2006 12 : 178 180. (Pubitemid 43214743)
-
(2006)
Nature Medicine
, vol.12
, Issue.2
, pp. 178-180
-
-
Ait-Oufella, H.1
Salomon, B.L.2
Potteaux, S.3
Robertson, A.-K.L.4
Gourdy, P.5
Zoll, J.6
Merval, R.7
Esposito, B.8
Cohen, J.L.9
Fisson, S.10
Flavell, R.A.11
Hansson, G.K.12
Klatzmann, D.13
Tedgui, A.14
Mallat, Z.15
-
13
-
-
36348967350
-
Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions
-
de Boer OJ, van der Meer JJ, Teeling P, van der Loos CM, van der Wal AC. Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions. PLoS ONE 2007 2 : e779.
-
(2007)
PLoS ONE
, vol.2
, pp. 779
-
-
De Boer, O.J.1
Van Der Meer, J.J.2
Teeling, P.3
Van Der Loos, C.M.4
Van Der Wal, A.C.5
-
15
-
-
33846980131
-
Epigenetic control of the foxp3 locus in regulatory T cells
-
Floess S, Freyer J, Siewert C et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol 2007 5 : e38.
-
(2007)
PLoS Biol
, vol.5
, pp. 38
-
-
Floess, S.1
Freyer, J.2
Siewert, C.3
-
16
-
-
33748465396
-
Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor
-
Marie JC, Liggitt D, Rudensky AY. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immunity 2006 25 : 441 454.
-
(2006)
Immunity
, vol.25
, pp. 441-454
-
-
Marie, J.C.1
Liggitt, D.2
Rudensky, A.Y.3
-
17
-
-
67649363839
-
Regulation of Rac1 by simvastatin in endothelial cells: Differential roles of AMP-activated protein kinase and calmodulin-dependent kinase kinase-beta
-
Kou R, Sartoretto J, Michel T. Regulation of Rac1 by simvastatin in endothelial cells: differential roles of AMP-activated protein kinase and calmodulin-dependent kinase kinase-beta. J Biol Chem 2009 284 : 14734 14743.
-
(2009)
J Biol Chem
, vol.284
, pp. 14734-14743
-
-
Kou, R.1
Sartoretto, J.2
Michel, T.3
-
19
-
-
0348223787
-
+ regulatory T cells by TGF-beta induction of transcription factor Foxp3
-
+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003 198 : 1875 1886.
-
(2003)
J Exp Med
, vol.198
, pp. 1875-1886
-
-
Chen, W.1
Jin, W.2
Hardegen, N.3
Lei, K.J.4
Li, L.5
Marinos, N.6
McGrady, G.7
Wahl, S.M.8
-
21
-
-
49649107703
-
DNA methylation controls Foxp3 gene expression
-
Polansky JK, Kretschmer K, Freyer J et al. DNA methylation controls Foxp3 gene expression. Eur J Immunol 2008 38 : 1654 1663.
-
(2008)
Eur J Immunol
, vol.38
, pp. 1654-1663
-
-
Polansky, J.K.1
Kretschmer, K.2
Freyer, J.3
|